More older adults died at their preferred place after implementation of a transmural care pathway for older adults at the end of life: a before-after study.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 11 10 2022
accepted: 03 07 2023
medline: 4 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

To improve transmural palliative care for older adults acutely admitted to hospital, the PalliSupport intervention, comprising an educational programme and transmural palliative care pathway, was developed. This care pathway involves timely identification of palliative care needs, advance care planning, multidisciplinary team meetings, warm handover, and follow-up home visits. With this study, we evaluate changes in patient-related outcomes and transmural collaboration after implementation of the care pathway. We conducted a before-after study, in which we compared 1) unplanned hospital admission and death at place of preference and 2) transmural collaboration before implementation, up to six months, and six to 18 months after implementation. Data from palliative care team consultations were collected between February 2017 and February 2020 in a teaching hospital in the Netherlands. The palliative care team held 711 first-time consultations. The number of consultation, as well as the number of consultations for patients with non-malignant diseases, and consultations for advance care planning increased after implementation. The implementation of the pathway had no statistically significant effect on unplanned hospitalization but associated positively with death at place of preference more than six months after implementation (during/shortly after adjusted OR: 2.12; 95% CI: 0.84-5.35; p-value: 0.11, long term after adjusted OR: 3.14; 95% CI: 1.49-6.62; p-value: 0.003). Effects on transmural collaboration showed that there were more warm handovers during/shortly after implementation, but not on long term. Primary care professionals attended multidisciplinary team meetings more often during and shortly after implementation, but did not more than six months after implementation. The pathway did not affect unplanned hospital admissions, but more patients died at their place of preference after implementation. Implementation of the pathway increased attention to- and awareness for in-hospital palliative care, but did not improve transmural collaboration on long-term. For some patients, the hospital admissions might helped in facilitating death at place of preference.

Sections du résumé

BACKGROUND BACKGROUND
To improve transmural palliative care for older adults acutely admitted to hospital, the PalliSupport intervention, comprising an educational programme and transmural palliative care pathway, was developed. This care pathway involves timely identification of palliative care needs, advance care planning, multidisciplinary team meetings, warm handover, and follow-up home visits. With this study, we evaluate changes in patient-related outcomes and transmural collaboration after implementation of the care pathway.
METHODS METHODS
We conducted a before-after study, in which we compared 1) unplanned hospital admission and death at place of preference and 2) transmural collaboration before implementation, up to six months, and six to 18 months after implementation. Data from palliative care team consultations were collected between February 2017 and February 2020 in a teaching hospital in the Netherlands.
RESULTS RESULTS
The palliative care team held 711 first-time consultations. The number of consultation, as well as the number of consultations for patients with non-malignant diseases, and consultations for advance care planning increased after implementation. The implementation of the pathway had no statistically significant effect on unplanned hospitalization but associated positively with death at place of preference more than six months after implementation (during/shortly after adjusted OR: 2.12; 95% CI: 0.84-5.35; p-value: 0.11, long term after adjusted OR: 3.14; 95% CI: 1.49-6.62; p-value: 0.003). Effects on transmural collaboration showed that there were more warm handovers during/shortly after implementation, but not on long term. Primary care professionals attended multidisciplinary team meetings more often during and shortly after implementation, but did not more than six months after implementation.
CONCLUSIONS CONCLUSIONS
The pathway did not affect unplanned hospital admissions, but more patients died at their place of preference after implementation. Implementation of the pathway increased attention to- and awareness for in-hospital palliative care, but did not improve transmural collaboration on long-term. For some patients, the hospital admissions might helped in facilitating death at place of preference.

Identifiants

pubmed: 37533107
doi: 10.1186/s12904-023-01218-0
pii: 10.1186/s12904-023-01218-0
pmc: PMC10394846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110

Subventions

Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands
Organisme : ZonMw
ID : 844001103
Pays : Netherlands

Informations de copyright

© 2023. The Author(s).

Références

J Oncol Pract. 2014 May;10(3):174-7
pubmed: 24839276
Crit Care Nurs Clin North Am. 2015 Sep;27(3):315-39
pubmed: 26333754
J Clin Oncol. 2011 Jun 10;29(17):2319-26
pubmed: 21555700
J Pain Symptom Manage. 2020 Aug;60(2):372-380.e1
pubmed: 32135201
Arch Gerontol Geriatr. 2022 Jul 26;103:104782
pubmed: 35917717
BMC Palliat Care. 2021 Jun 5;20(1):81
pubmed: 34090394
Palliat Med. 2023 Jan;37(1):75-87
pubmed: 36541477
N Engl J Med. 2013 Mar 28;368(13):1173-5
pubmed: 23465068
BMJ Support Palliat Care. 2014 Sep;4(3):285-90
pubmed: 24644193
Pilot Feasibility Stud. 2020 Sep 15;6:129
pubmed: 32944277
PLoS One. 2015 Mar 10;10(3):e0118971
pubmed: 25756184
BJOG. 2018 Dec;125(13):1716
pubmed: 29916205
BMJ Qual Improv Rep. 2013 Aug 21;2(1):
pubmed: 26734208
Palliat Med. 2015 Sep;29(8):703-10
pubmed: 25769983
Patient Educ Couns. 2000 Feb;39(2-3):177-84
pubmed: 11040717
Palliat Med. 2011 Jun;25(4):382
pubmed: 21610113
J Am Med Dir Assoc. 2021 Feb;22(2):297-304
pubmed: 33221300
Lancet Oncol. 2017 Sep;18(9):e543-e551
pubmed: 28884703
BMC Health Serv Res. 2016 Sep 23;16(1):518
pubmed: 27663961
BMJ. 2010 Mar 23;340:c1345
pubmed: 20332506
Int J Nurs Stud. 2020 Sep;109:103609
pubmed: 32603926
Palliat Med. 2009 Jan;23(1):23-8
pubmed: 18952748
Palliat Med. 2014 Oct;28(9):1081-98
pubmed: 24821710
J Pain Symptom Manage. 2019 Oct;58(4):721-734.e1
pubmed: 31201875
BMC Palliat Care. 2019 Jul 9;18(1):54
pubmed: 31288816
Palliat Med. 2014 Apr 2;28(7):949-958
pubmed: 24694377
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717

Auteurs

Iris van Doorne (I)

Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam University Medical Center, University of Amsterdam, Room D3-335, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. i.vandoorne@amsterdamumc.nl.
Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands. i.vandoorne@amsterdamumc.nl.
Center of Expertise Urban Vitality, Faculty of Health, Amsterdam University of Applied Science, Amsterdam, the Netherlands. i.vandoorne@amsterdamumc.nl.

Marike A de Meij (MA)

Palliative and Supportive Care Team, Oncology Center Amsterdam, OLVG, Oosterpark 9, Amsterdam, The Netherlands.

Juliette L Parlevliet (JL)

Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam University Medical Center, University of Amsterdam, Room D3-335, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.

Vera M W van Schie (VMW)

Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam University Medical Center, University of Amsterdam, Room D3-335, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.

Dick L Willems (DL)

General Practice, Section of Medical Ethics, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Bianca M Buurman (BM)

Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam University Medical Center, University of Amsterdam, Room D3-335, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
Center of Expertise Urban Vitality, Faculty of Health, Amsterdam University of Applied Science, Amsterdam, the Netherlands.
Amsterdam UMC Location Vrije Universiteit, Medicine for Older People, Boelelaan 1117, Amsterdam, The Netherlands.

Marjon van Rijn (M)

Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam University Medical Center, University of Amsterdam, Room D3-335, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
Center of Expertise Urban Vitality, Faculty of Health, Amsterdam University of Applied Science, Amsterdam, the Netherlands.
Amsterdam UMC Location Vrije Universiteit, Medicine for Older People, Boelelaan 1117, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH